« Back
Home /
T-705 (Favipiravir)

T-705 (Favipiravir)

Manufacturer	Adooq
Category	Infectious Diseases Viral Infections Coronavirus (COVID-19) Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	10mg
Item no.	A11590-10
CASRN	259793-96-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Short Description	T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
Cas No	259793-96-9
Synonyms	T705, T 705
Formula	C5H4FN3O2
Solubilty	DMSO
Purity	>98%
Chemical Name	6-Fluoro-3-hydroxy-2-pyrazinecarboxamide 6-fluoro-3, 4-dihydro-3-oxo-Pyrazinecarboxamide
M. Wt.	157, 1
SMILES	C1=C(N=C(C(=O)N1)C(=O)N)F
Storage	2 years at -20C
Note	Please note, this is not a medicine. There is no sale to doctors, pharmacies or private persons!

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

A11590-10.pdf

A11590-10-datasheet.pdf

A11590-10-safety-datasheet.pdf